Manufacturing

EU chip factory fantasy puts cart before horse

26 Feb 2021

Commissioner Thierry Breton wants an advanced semiconductor plant to cut reliance on Asia. The problem is that Europe’s chip designers and carmakers are ill-equipped to use such a cutting-edge site. Getting them on side, and investing more in research, is the place to start.

Chip deal price bump shifts spotlight to Berlin

25 Jan 2021

Taiwan’s GlobalWafers raised its offer for Siltronic to $5.3 bln and cut the acceptance threshold to 50%. It’s probably enough to get the bid over the line. The next question is whether Germany will give up control of a semiconductor supplier. Investors may be too sanguine.

Europe’s chip darling may fall victim to its hype

20 Jan 2021

ASML’s market value has risen by two-thirds in the past year to $230 bln, helped by surging demand for its kit. Yet CEO Peter Wennink will struggle to meet investors’ heady growth hopes. A drawn-out trade war between China and America would make his job even harder.

Corona Capital: Bond bonanza, Albertsons

12 Jan 2021

Concise views on the pandemic’s corporate and financial fallout: U.S. companies' bond issuance in 2020 hits records across the board; and America’s No. 3 grocer continues to take advantage of the shopping habits created by Covid-19 lockdowns.

Brexit throws down electric gauntlet to UK cars

4 Jan 2021

Britain’s motor industry has escaped European Union tariffs that would have hobbled half its output. But to meet export rules on low-carbon vehicles by 2024, Prime Minister Boris Johnson needs to ramp up battery output. Convincing groups like Nissan and BMW to stay will be tough.

Corona Capital: Icahn, Productivity, Natixis

4 Jan 2021

Concise views on the pandemic’s corporate and financial fallout: Carl Icahn sells half his Herbalife Nutrition stake; an ECB survey suggests Covid-19 will make big firms more productive, but that may not be all good news; and Natixis fast-tracks its overhaul.

The Franken-economy that will thrive post-pandemic

24 Dec 2020

The ideal nation to emerge from Covid-19 has South Korea’s superb internet connections and technology know-how. Like Singapore, robots are widely used in industry. And it boasts skilled workers to rival Switzerland, sells high-value exports to China, and leads on green energy.

Rubber-glove selloff gets out of hand

16 Dec 2020

The pandemic quadrupled the value of Malaysia’s Top Glove, the world’s biggest maker of protective handwear, to $13 bln. But investors eying vaccine developments are now deeply discounting its shares. As the herd hastily dumps Covid trades, there will be value left behind.

Corona Capital: Record Dow, Basketball, GoCompare

25 Nov 2020

Concise views on the pandemic’s corporate and financial fallout: Vaccine optimism shunts the blue-chip Dow Jones index through 30,000; U.S. college basketball gets back on the court; and UK publisher Future snaps up the bargain-hunting website.

Corona Capital: Tiffany, Biden, Vaccines, Cash box

24 Nov 2020

Concise views on the pandemic’s corporate and financial fallout: The cut-price jeweller issues less-than-sparkling results; the U.S. president-elect gets to start tackling the pandemic; Russia touts its discount vaccine; and UK firms gorge on shareholder-unfriendly equity issues.

Thyssenkrupp is acid test of German green resolve

19 Nov 2020

The ailing giant’s steel arm lost 950 mln euros last year and is a major carbon dioxide polluter. Right now it would cost a bomb to convert the division into a hydrogen-powered, low-carbon star. Still, extending subsidies would chime with Berlin’s commitment to a green recovery.

Corona Capital: Cars, Kalashnikovs, Houses

6 Nov 2020

Concise views on the pandemic’s corporate and financial fallout: Japanese carmakers put their feet down thanks to China’s bounceback; Russia’s Kalashnikov gets a new owner; and rich-country housing markets look surprisingly cheery.

Corona Capital: Quibi

22 Oct 2020

Concise views on the pandemic’s corporate and financial fallout: Video streaming company Quibi’s failure is in spite of – not because of – the Covid-19 pandemic.

Corona Capital: Vaccine yields, Halliburton, Glovo

19 Oct 2020

Concise views on the pandemic’s corporate and financial fallout: Corporate bond investors are nearly as worried about a vaccine crimping the market as they are about inflation; oil services firms get three times unlucky; Delivery Hero acts like one despite investor skepticism.

Boeing has got a bigger than MAX problem

16 Oct 2020

Europe’s aviation regulator said the troubled 737 is safe to fly, sending the $92 bln aircraft producer’s shares up 5%. Even when sales return, ongoing reductions of flight schedules due to Covid-19 will make Boeing’s woes linger. There’s a chance they become permanent.

Corona Capital: Black Friday, JPMorgan’s new tower

14 Oct 2020

Concise views on the pandemic’s corporate and financial fallout: Walmart’s Black Friday rejig makes for a curious experiment; JPMorgan goes all-in on New York real estate.

Face mask boom has unhealthy side effects

5 Oct 2020

Companies from Chinese carmaker BYD to retailer Gap have cashed in on demand for masks. Entrepreneurs and crooks have also piled in, leading to quality problems and fraud. As panic-buying winds down, dealing with excess capacity and used-mask trash could be a headache.

Rolls-Royce repair job has 18-month warranty

29 Sep 2020

The UK jet engine maker wants to raise 2.5 bln pounds from existing and new investors, including sovereign funds. That should keep it aloft even if the airlines that use its kit have a bad 2021. Beyond that, a slow recovery could mean more financial warning lights.

Corona Capital: U.S. sports’ virus-bubble success

29 Sep 2020

Concise views on the pandemic’s corporate and financial fallout: Professional hockey and basketball associations scored victories keeping infection rates low or at zero in spectator-free games. And less traveling and more sleep helped players up their game. Wall Street take note.

Rolls-Royce self-harms by selling family silver

27 Aug 2020

The British jet-engine maker wants to offload its Spanish turbine-blade unit to patch up its Covid-hit balance sheet. Creditors will be as gleeful as shareholders are glum. If Rolls survives the crisis – and that’s an increasingly big if – it will be with a permanent limp.